sbeefyk2 wrote:
Nike will ALWAYS promote shareholder value (i.e. increasing cash flows and profits) over taking the side of anti-doping. There's big money in supporting doped athletes.
Look at how much money Nike made off Lance Armstrong. After Lance was busted Nike wasn't penalized at all. Lance was, but Nike didn't have to repay all the profits they made off Lance. It would be naive to think Nike didn't know Lance was doping the whole time.
Same story for the NOP. Nike was aware of the doping regime and once it was uncovered they closed the doors on the NOP. Again, it would be naive to think otherwise.
I'm not saying Nike wasn't aware of the doping, but how much is NOP really driving shareholder value? NOP - as I understand it - was Phil's (and Mark's it seems, maybe others') passion project. I cannot imagine it returned shareholder value. If sponsoring a running group does, I can't imagine its because of one group over another. NOP existed because Phil wanted to see an American medal in distance events, just like he wanted to see Oregon return to its glory days. I'm not sure there is big money in supporting doped track athletes, especially American distance runners.* Just big egos.
Lance on the other hand made money for Nike. No dispute there.
* This may be changing with the 4%. They were everywhere in Chicago. This may be the first racing shoe that moves a needle for Nike beyond driving long-term brand loyalty. So, in theory, the hype for the 4% could be increased if those running in it are doped and their times are attributable only to the shoes in the mind of the common consumer.